NicAdams

CBS - At The Bottom of 5 Year Broadening Formation

Long
NicAdams Updated   
NYSE:CBS   None

Very large broadening formation formed on the monthly dating back to 2013.
Current R:R ratio with a stop under the previous month low and a reward to the top of the broadening formation is 9:1.
Smart move would be to wait until previous month high is breached and get a confirmation close 3day at least and gauge risk from there.
But something tells me that a strong gap up won't give you that opportunity.
The risk of taking a small starter position here with strong closes is worth a look.
Beware: earnings next week...

Comment:
On the radar:
Strong buy entry above $40.76 when it takes the month up, with the near term target of stopping out the shorts sitting above the October high $41.09.
This should add enough fuel to attempt to squeeze out any remaining stops placed above the Dec 2018 lows of $41.38.
A daily close above $41.38 is very strong.
Near term target would then be $46.42, the 2019 Q2 lows.
Mid term target $53.72, expanding the previous quarter to the upside.
Long term target $70.10+ into new all-time highs.

Initial entry: $40.76
Stop: $39.72
Target 1: $46.42 (r:r 5.51)
Target 2: $53.72 (r:r 12.59)
Target 3: 70.10 (r:r 28.5)
Comment:
On the radar..
All hands man your battle stations.
$40.76 potentially incoming, stop revised to $39.59.
Risk of 2.87%, manage your position size accordingly.
Trade active:
Buy engaged at $40.76.
Stop at $39.59.
Target 1: $46.42 (r:r 4.84)
Target 2: $53.72 (r:r 11.08)
Target 3: 70.10 (r:r 25.08)
Comment:
Full time frame continuity to the upside. Add on every hourly new high, move stop under the hourly low.
Comment:
A little late on this but the CBS / Viacom merger creates ticker VIAC.
I was stopped out at $37.37, nearly the low for the day, but re-entered at $39.84.
If stopped out again on the days low will just have to re-evaluate next week.
I'm not sure what the price action will hold post merger so will probably move on to something else.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.